Cargando…
Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy
SIMPLE SUMMARY: The treatment of cancer has progressed greatly with the advent of immunotherapy and gene therapy, including the use of nonreplicating adenoviral vectors to deliver genes with antitumor activity for cancer gene therapy. Even so, the successful application of these vectors may benefit...
Autores principales: | Tessarollo, Nayara Gusmão, Domingues, Ana Carolina M., Antunes, Fernanda, da Luz, Jean Carlos dos Santos, Rodrigues, Otavio Augusto, Cerqueira, Otto Luiz Dutra, Strauss, Bryan E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069790/ https://www.ncbi.nlm.nih.gov/pubmed/33919679 http://dx.doi.org/10.3390/cancers13081863 |
Ejemplares similares
-
Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene delivery
por: Wang, Y, et al.
Publicado: (2005) -
Perspectives for Combining Viral Oncolysis With Additional Immunotherapies for the Treatment of Melanoma
por: Cerqueira, Otto Luiz Dutra, et al.
Publicado: (2022) -
Clinical Applications and Immunological Aspects of Electroporation-Based Therapies
por: da Luz, Jean Carlos dos Santos, et al.
Publicado: (2021) -
Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors
por: Coughlan, Lynda, et al.
Publicado: (2010) -
CELO Fiber1 Knob Is a Promising Candidate to Modify the Tropism of Adenoviral Vectors
por: Sun, Yangyang, et al.
Publicado: (2022)